Literature DB >> 1383336

Inhibition of macrophage protein kinase C-mediated protein phosphorylation by Leishmania donovani lipophosphoglycan.

A Descoteaux1, G Matlashewski, S J Turco.   

Abstract

The cell surface lipophosphoglycan (LPG) from Leishmania donovani promastigotes is a potent inhibitor of purified protein kinase C (PKC) activity in vitro. In this study, we have investigated the effect of LPG on the activation process of PKC in murine bone marrow-derived macrophages. The extent and kinetics of calcium ionophore A23187-induced [3H] phorbol dibutyrate binding to macrophages were not affected by LPG pretreatment or infection with either wild-type or LPG-deficient promastigotes, indicating no effect on the association of calcium-dependent PKC with the plasma membrane. In contrast, LPG inhibited the phosphorylation of both the PKC-specific VRKRTRLLR substrate peptide and MARCKS, and endogenous PKC substrate, in 1-oleoyl-2-acetyl-glycerol-stimulated macrophages. These observations provide direct evidence that LPG effectively inhibits PKC activity in intact macrophages. Finally, depletion of PKC rendered macrophages more permissive for the proliferation of L. donovani, suggesting that inhibition of PKC-dependent events contributes to the survival of this parasite within its host cell.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1383336

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  44 in total

1.  Ligation of Fc receptor of macrophages stimulates protein kinase C and anti-leishmanial activity.

Authors:  D Dasgupta; P Chakraborty; M K Basu
Journal:  Mol Cell Biochem       Date:  2000-06       Impact factor: 3.396

2.  Regulation of impaired protein kinase C signaling by chemokines in murine macrophages during visceral leishmaniasis.

Authors:  Ranadhir Dey; Arup Sarkar; Nivedita Majumder; Suchandra Bhattacharyya Majumdar; Kaushik Roychoudhury; Sandip Bhattacharyya; Syamal Roy; Subrata Majumdar
Journal:  Infect Immun       Date:  2005-12       Impact factor: 3.441

3.  Distribution of protein kinase C isoforms after infection of macrophages with Leishmania major.

Authors:  S Pingel; Z E Wang; R M Locksley
Journal:  Infect Immun       Date:  1998-04       Impact factor: 3.441

4.  The curative effect of fucoidan on visceral leishmaniasis is mediated by activation of MAP kinases through specific protein kinase C isoforms.

Authors:  Gunjan Sharma; Susanta Kar; Writoban Basu Ball; Kuntal Ghosh; Pijush K Das
Journal:  Cell Mol Immunol       Date:  2014-02-24       Impact factor: 11.530

5.  The role of phosphoglycans in Leishmania-sand fly interactions.

Authors:  D L Sacks; G Modi; E Rowton; G Späth; L Epstein; S J Turco; S M Beverley
Journal:  Proc Natl Acad Sci U S A       Date:  2000-01-04       Impact factor: 11.205

6.  Transbilayer inhibition of protein kinase C by the lipophosphoglycan from Leishmania donovani.

Authors:  J R Giorgione; S J Turco; R M Epand
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-15       Impact factor: 11.205

Review 7.  Subversion mechanisms by which Leishmania parasites can escape the host immune response: a signaling point of view.

Authors:  Martin Olivier; David J Gregory; Geneviève Forget
Journal:  Clin Microbiol Rev       Date:  2005-04       Impact factor: 26.132

8.  Structures of Leishmania major orthologues of macrophage migration inhibitory factor.

Authors:  Julia M Richardson; Lesley S Morrison; Nicholas D Bland; Sandra Bruce; Graham H Coombs; Jeremy C Mottram; Malcolm D Walkinshaw
Journal:  Biochem Biophys Res Commun       Date:  2009-01-31       Impact factor: 3.575

Review 9.  Leishmania interferes with host cell signaling to devise a survival strategy.

Authors:  Suvercha Bhardwaj; Neetu Srivastava; Raki Sudan; Bhaskar Saha
Journal:  J Biomed Biotechnol       Date:  2010-04-08

10.  Leishmania major amastigotes induce p50/c-Rel NF-kappa B transcription factor in human macrophages: involvement in cytokine synthesis.

Authors:  Lamia Guizani-Tabbane; Khadija Ben-Aissa; Meriam Belghith; Atfa Sassi; Koussay Dellagi
Journal:  Infect Immun       Date:  2004-05       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.